72
Participants
Start Date
November 1, 2012
Primary Completion Date
April 1, 2014
Study Completion Date
December 1, 2014
Liraglutide
"Patients randomized to 1.2 mg of liraglutide : They will start liraglutide 0.6 mg sc once daily for one week and will increase the dose to 1.2 mg sc once daily thereafter.~Patients randomized to 1.8 mg of liraglutide: They will start liraglutide 0.6 mg sc once daily for one week; will increase to 1.2 mg sc once daily for second week and will stay on 1.8 mg of liraglutide from third week onwards."
Placebo
"Patients randomized to 1.2 mg of placebo: They will start placebo 0.6 mg sc once daily for one week and then increase to 1.2 mg once daily thereafter.~Patients randomized to 1.8 mg of placebo: They will start placebo 0.6 mg sc once daily for one week; increase to 1.2 mg sc once daily for second week and then to 1.8 mg sc once daily from third week onwards."
Diabetes-Endocrinology Center of Western NY, Williamsville
Collaborators (1)
Novo Nordisk A/S
INDUSTRY
University at Buffalo
OTHER